European Pharmaceutical Review

MAY 2, 2024

Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures. There have been upward of 1,900 precision medicine clinical trials conducted to date. Available from: [link] The post What is the future of biologic medicines?

Medicine 105

Medicine Manufacturing Biopharma Engineering 105

Fierce Pharma

NOVEMBER 15, 2024

With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling down on the nuclear medicine craze. Dubbed the Advanced Thorium Extraction Facility, the new 7,000-square-meter site is slated to manufacture thorium-228, a precursor of lead-212, for radioligand therapies.

Manufacturing 217

Manufacturing Medicine Leads 217

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105

Medicine Side effects Healthcare Healthcare 105

Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

MAY 18, 2023

A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA.

Medicine 98

Medicine Distribution Manufacturing Management 98

European Pharmaceutical Review

NOVEMBER 15, 2023

[Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Manufacturing Networking Biopharma 93

Fierce Pharma

SEPTEMBER 20, 2024

Europe’s Committee for Medicinal Products for Human Use has confirmed its negative stance on pegcetacoplan in geographic atrophy, an advanced form of age-related macular degeneration that can lead to blindness. This marks the third rejection this year for pegcetacoplan in Europe.

Prospecting 269

Prospecting Medicine Leads Pharmaceutical 269

European Pharmaceutical Review

NOVEMBER 10, 2022

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). What constitutes a complex medicine?

Medicine 105

Medicine Distribution Engineering Electronics 105

Pharmaceutical Technology

MAY 24, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Recombinant viral vector-based medicinal preparations. However, not all innovations are equal and nor do they follow a constant upward trend.

Medicine 52

Medicine Pharmaceutical Leads Prescription 52

pharmaphorum

JANUARY 17, 2023

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool.

Medicine 98

Medicine Patients Transportation Healthcare 98

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

Contrarian Sales Techniques

NOVEMBER 18, 2024

Imagine getting your medicines delivered right to your doorstep, without stepping out of the house. With platforms like Esyms and DoctorOnCall leading the way, Malaysians can now order prescription and over-the-counter medications online, and have them delivered directly to their homes. Sounds convenient, right?

Medicine 40

Medicine Pharma sales reps Safety Healthcare 40

European Pharmaceutical Review

FEBRUARY 2, 2023

While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111

European Pharmaceutical Review

AUGUST 22, 2024

billion” last year, two key players in the market, namely Novo Nordisk and Eli Lilly and Company, are set to lead the market, the analytics company forecasts: “collectively capturing 94 percent of the total 2030 GLP-1R sales”. Eli Lilly shared that production of the medicines will commence at the Lebanon site towards the end of 2026.

Medicine 59

Medicine Marketing Manufacturing Sales 59

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 116

Medicine Management Marketing Leads 116

Fierce Pharma

OCTOBER 10, 2023

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies.

Prospecting 320

Prospecting Manufacturing Medicine Leads 320

Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 98

Medicine Marketing Leads 98

pharmaphorum

JANUARY 20, 2023

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. This makes clear just what is most important.

Medicine 98

Medicine Government Patients Management 98

European Pharmaceutical Review

JANUARY 25, 2023

The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for exagamglogene autotemcel (exa-cel), the first regulatory submission for a CRISPR-based medicine. Under an amended collaboration agreement, Vertex now leads global development, manufacturing and commercialisation of exa-cel.

Medicine 111

Medicine Food and Drug Administration FDA Pharmaceutical 111

Pharmaceutical Technology

JANUARY 16, 2023

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine 119

Medicine Food and Drug Administration Food Medical 119

European Pharmaceutical Review

JANUARY 11, 2024

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 102

Medicine Pharmacology Management Side effects 102

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.

Manufacturing 109

Manufacturing Medicine Government Pharmaceutical manufacturing 109

European Pharmaceutical Review

JULY 19, 2022

Transpire Bio and Recipharm have signed a definitive agreement for the development of TRB-1 and TRB-2 – two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). We are very excited to be working with Recipharm to advance these important medicines.”. million lives lost. About Transpire Bio.

Medicine 105

Medicine Manufacturing Pharmaceutical Pharmaceutical products 105

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in personalized cancer vaccines for the pharmaceutical industry.

Leads 52

Leads Medicine Pharmaceutical 52

MedCity News

SEPTEMBER 20, 2023

This accelerates lead identification and optimization, offering researchers a broader pool of candidates to choose from. From revolutionizing drug discovery and design to enabling personalized medicine and accelerating research, the benefits are vast and diverse.

Ethics 104

Ethics Medicine Pharmaceutical Pharmaceutical research 104

MedCity News

JULY 7, 2023

This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.

Leads 124

Leads Medicine 124

European Pharmaceutical Review

JANUARY 18, 2023

Pfizer has announced it is expanding its ‘An Accord for a Healthier World’ initiative, to include its full portfolio of medicines and vaccines for which Pfizer has global rights. The initial not-for-profit offering provided access to all its patented medicines and vaccines available in the US or European Union (EU) to 1.2

Medicine 98

Medicine Government Pharma Leads 98

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Worldwide sourcing and drop-ship of orphan medicines, and. Worldwide sourcing and drop-ship of orphan medicines, and.

Leads 52

Leads Pharmaceutical Customer Relationship Management Retail 52

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology. Optimise your cell therapy process: a guide to cell thawing.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. The evolving field of genomic medicine. This is just the beginning; the potential is enormous,” he says.

Medicine 95

Medicine Patients Healthcare Healthcare 95

Fierce Pharma

JUNE 6, 2024

Amid a nuclear medicine boom, France’s Orano Med has chosen the U.S. The site marks the world’s first industrial-scale facility dedicated to production of lead-212-based radioligand therapies, the company said. to establish a manufacturing plant as it progresses on its radiopharma journey.

Manufacturing 241

Manufacturing Medicine Leads 241

European Pharmaceutical Review

JUNE 14, 2023

To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9

Medicine 52

Medicine Manufacturing Government Competition 52

Fierce Pharma

NOVEMBER 1, 2023

In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky talks with the study lead, Reisa Sperling, M.D., to learn more.

Medicine 228

Medicine Leads 228

pharmaphorum

JANUARY 27, 2023

So, here are three “best guesses” for what 2023 will hold for the off-patent medicines segment — which accounts for roughly 70% of medicines prescribed worldwide (including the vast majority of system-critical antibiotics and ICU therapies), but only about 20% of the total cost.

Medicine 93

Medicine Government Marketing Transportation 93

PharmaTech

OCTOBER 6, 2023

The BioIndustry Association reports that with a strong foundation in research and development in mRNA the United Kingdom will be a major player in this rapidly growing industry.

Leads 52

Leads Medicine 52

pharmaphorum

OCTOBER 12, 2022

The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. The group will be leading a workshop on the topic at Frontiers Health next week. Translational medicine and digital health.

Medicine 106

Medicine Training Education Healthcare 106

pharmaphorum

NOVEMBER 18, 2022

Gene-testing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial. The post After disappointing trial, Editas puts lead CRISPR drug up for sale appeared first on.

Leads 92

Leads Sales Medicine Patients 92